PF-Atlas › Clinical Trials › NCT04017936
Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
Anakinra · Phase 2
Registry ID
NCT04017936
Phase
Phase 2
Status
Completed
Drug / intervention
Anakinra
Sponsor
Virginia Commonwealth University
Start
2020-10-23
About this trial
Anakinra is evaluated in NCT04017936, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Virginia Commonwealth University. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04017936 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.